Home LiteratureArticle Details
PMID: 6251708 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Antibody-mediated destruction of virus-infected cells.

Advances in immunology ·Vol. 29 ·1980-00-00 ·Pages 209-60

Sissons JG, Oldstone MB

Abstract

暂无摘要

MeSH Terms
Antibodies, Viral/biosynthesis Antibody-Dependent Cell Cytotoxicity Antigens, Surface Antigens, Viral Binding Sites, Antibody Complement Pathway, Alternative Cytotoxicity, Immunologic Immunoglobulin G RNA Viruses/immunology Receptors, Fc Simplexvirus/immunology Viral Proteins/biosynthesis Virus Diseases/immunology
Chemicals
Antibodies, Viral Antigens, Surface Antigens, Viral Immunoglobulin G Receptors, Fc Viral Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sissons J G
Oldstone M B
References (163)
163 references, click to expand
  1. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
    J Immunol. 1978 Aug;121(2):532-8 PMID: 150448
  2. Evaluation of the role of IgG antibodies in human natural cell-mediated cytotoxicity against the myeloid cell line K562.
    J Immunol. 1979 Feb;122(2):675-85 PMID: 368247
  3. Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2406-10 PMID: 307764
  4. Antibody-induced capping of measles virus antigens on plasma membrane studied by electron microscopy.
    J Virol. 1975 May;15(5):1248-55 PMID: 49437
  5. A comparison of the polypeptides of four measles virus strains.
    Virology. 1977 May 15;78(2):463-74 PMID: 867814
  6. Immunoglobulin-independent natural cytotoxicity of Fc receptor-bearing human blood lymphocytes to mumps virus-infected target cells.
    J Immunol. 1978 Aug;121(2):755-61 PMID: 308078
  7. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.
    Infect Immun. 1977 Apr;16(1):43-7 PMID: 194838
  8. An in vitro method for study of human lymphocyte cytotoxicity against mumps-virus-infected target cells.
    J Immunol. 1975 Jan;114(1 Pt 1):237-43 PMID: 803527
  9. Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. II. Relationship of the anti-lymphocytic choriomeningitis immune response to tissue injury in chronic lymphocytic choriomeningitis disease.
    J Exp Med. 1970 Jan 1;131(1):1-19 PMID: 5460613
  10. Antibody-induced redistribution of virus antigens on the surface of influenza virus-infected cells.
    J Gen Virol. 1976 Nov;33(2):321-32 PMID: 792397
  11. Membrane Glycoproteins of Enveloped Viruses.
    Curr Top Membr Transp. 1978;11:233-277 PMID: 32287477
  12. Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands.
    Proc Natl Acad Sci U S A. 1977 Nov;74(11):5031-5 PMID: 337308
  13. Undisturbed release of influenza virus in the presence of univalent antineuraminidase antibodies.
    Virology. 1971 Nov;46(2):337-43 PMID: 5167068
  14. The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin.
    J Immunol. 1976 Jun;116(6):1566-70 PMID: 178801
  15. Studies on the effect of specific antisera on the metabolism of cellular antigens. II. The synthesis and degradation of TL antigens of mouse cells in the presence of TL antiserum.
    J Immunol. 1974 Apr;112(4):1296-307 PMID: 4360860
  16. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
    J Immunol. 1977 Feb;118(2):558-66 PMID: 190316
  17. Antibody-modification of measles "in vitro" infection.
    J Med Virol. 1977;1(2):111-7 PMID: 417148
  18. Subacute sclerosing panencephalitis: experimental infection in primates.
    Science. 1977 Jan 7;195(4273):64-6 PMID: 831255
  19. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
    J Infect Dis. 1975 Sep;132(3):262-9 PMID: 1159329
  20. Immune responses to influenza virus in the mouse, and their role in control of the infection.
    Br Med Bull. 1979 Jan;35(1):65-8 PMID: 367489
  21. Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus.
    Clin Exp Immunol. 1977 Apr;28(1):19-26 PMID: 862248
  22. An analysis of the murine NK cell as to structure, function and biological relevance.
    Immunol Rev. 1979;44:165-208 PMID: 367949
  23. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
    Proc Natl Acad Sci U S A. 1977 Apr;74(4):1683-7 PMID: 266208
  24. Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus.
    J Immunol. 1976 Jul;117(1):253-8 PMID: 180179
  25. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    J Natl Cancer Inst. 1972 Jul;49(1):183-92 PMID: 5037434
  26. Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2.
    J Immunol. 1972 Sep;109(3):554-64 PMID: 4341272
  27. Latent measles virus infection of the hamster central nervous system.
    J Immunol. 1971 Dec;107(6):1593-8 PMID: 5120399
  28. Effect of cytochalasin B on the maturation of enveloped viruses.
    J Exp Med. 1979 Aug 1;150(2):379-91 PMID: 222875
  29. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.
    J Immunol. 1976 Jul;117(1):208-15 PMID: 819582
  30. Antibody-dependent cytolytically active human leukocytes: an analysis of inactivation following in vitro interaction with antibody-coated target cells.
    J Immunol. 1975 Dec;115(6):1500-4 PMID: 1184963
  31. Selective incorporation of H-2 antigenic determinants into Friend virus particles.
    Nature. 1977 Mar 31;266(5601):458-9 PMID: 67564
  32. Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia.
    J Exp Med. 1977 Aug 1;146(2):520-34 PMID: 327016
  33. The IgG receptor induced by herpes simplex virus: studies using radioiodinated IgG.
    J Gen Virol. 1974 Jul;24(1):167-78 PMID: 4367308
  34. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    J Exp Med. 1975 Oct 1;142(4):856-63 PMID: 1185108
  35. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
    J Immunol. 1976 Jan;116(1):194-201 PMID: 173757
  36. Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets.
    Immunol Rev. 1979;44:71-123 PMID: 367950
  37. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.
    J Exp Med. 1978 Dec 1;148(6):1722-7 PMID: 722244
  38. The pathogenesis of Aleutian disease of mink. II. Enhancement of tissue lesions following the administration of a killed virus vaccine or passive antibody.
    J Immunol. 1972 Jul;109(1):1-7 PMID: 4556259
  39. Human serum lyses RNA tumour viruses.
    Nature. 1975 Oct 16;257(5527):612-4 PMID: 170540
  40. A comparison of immune cytolysis and virus-induced fusion of sensitive and resistant cell types.
    Proc Soc Exp Biol Med. 1969 Jun;131(2):651-7 PMID: 4306811
  41. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.
    J Gen Virol. 1979 Jul;44(1):205-15 PMID: 227991
  42. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
    J Exp Med. 1976 Oct 1;144(4):970-84 PMID: 62019
  43. C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions.
    J Exp Med. 1979 Feb 1;149(2):448-58 PMID: 762498
  44. Changes in the surface of virus-induced cells recognized by cytotoxic T cells. I. Minimal requirements for lysis of ectromelia-infected P-815 cells.
    Scand J Immunol. 1976;5(1-2):23-30 PMID: 178048
  45. Immune lysis of rabies virus-infected cells.
    J Immunol. 1968 Dec;101(6):1271-82 PMID: 5749193
  46. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.
    J Exp Med. 1977 Oct 1;146(4):949-69 PMID: 302316
  47. Subacute sclerosing panencephalitis. Immunoultrastructural localization of measles-virus antigen.
    Arch Pathol. 1973 Feb;95(2):81-9 PMID: 4345667
  48. Antibody-induced redistribution of measles virus antigens on the cell surface.
    J Immunol. 1974 Oct;113(4):1205-9 PMID: 4606230
  49. The role of complement in the HL-A antibody-mediated lysis of lymphocytes.
    Transplant Proc. 1974 Mar;6(1):13-9 PMID: 4856285
  50. Spontaneous and induced cytotoxic properties of human adherent mononuclear cells: killing of non-sensitized and antibody-coated non-erythroid cells.
    Immunology. 1979 Feb;36(2):221-8 PMID: 220181
  51. Binding of antibodies to isolated haemagglutinin and neuraminidase molecules of influenza virus observed in the electron microscope.
    J Mol Biol. 1977 Jan 25;109(3):405-21 PMID: 64612
  52. Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation.
    J Exp Med. 1975 Oct 1;142(4):864-76 PMID: 1176889
  53. Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes.
    J Immunol. 1977 Dec;119(6):2100-6 PMID: 334984
  54. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
    J Exp Med. 1976 May 1;143(5):1027-41 PMID: 177712
  55. Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria.
    Transplant Rev. 1974;19(0):3-55 PMID: 4135465
  56. A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway.
    Proc Natl Acad Sci U S A. 1973 Mar;70(3):649-52 PMID: 4123687
  57. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.
    Proc Natl Acad Sci U S A. 1980 Jan;77(1):559-62 PMID: 6928644
  58. Externally disposed plasma membrane proteins. II. Metabolic fate of iodinated polypeptides of mouse L cells.
    J Cell Biol. 1975 Feb;64(2):461-79 PMID: 163834
  59. Immunopathological aspects in the pathogenesis of subacute sclerosing panencephalitis, with special reference to the significance of the immune response in the central nervous system.
    Ann Clin Res. 1973 Oct;5(5):308-15 PMID: 4600416
  60. Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells.
    Infect Immun. 1976 May;13(5):1433-41 PMID: 1270149
  61. Persistent infection of cells in culture by measles virus. II. Effect of measles antibody on persistently infected HeLa sublines and recovery of a HeLa clonal line persistently infected with incomplete virus.
    J Bacteriol. 1966 Dec;92(6):1805-11 PMID: 5334769
  62. Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes.
    J Exp Med. 1976 Feb 1;143(2):271-89 PMID: 1082488
  63. Formation of SV40 specific and H-2 restricted target cell antigen by somatic cell fusion.
    Nature. 1980 Jan 3;283(5742):74-6 PMID: 6243176
  64. Maintenance of latent herpetic infection: an apparent role for anti-viral IgG.
    J Immunol. 1974 Dec;113(6):1685-93 PMID: 4372269
  65. Synchronised transmembrane insertion and glycosylation of a nascent membrane protein.
    Nature. 1977 Oct 27;269(5631):775-80 PMID: 200844
  66. Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction.
    Adv Immunol. 1976;24:37-165 PMID: 798475
  67. Asymmetric budding of viruses in epithelial monlayers: a model system for study of epithelial polarity.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):5071-5 PMID: 283416
  68. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
    J Exp Med. 1975 Apr 1;141(4):761-74 PMID: 1092789
  69. Human histocompatibility determinants and virus antigens: effect of measles virus infection on HLA expression.
    J Exp Med. 1977 Jul 1;146(1):146-56 PMID: 68989
  70. Human lymphocyte subpopulations.
    Adv Immunol. 1977;25:213-41 PMID: 76434
  71. Polar appearance and nonligand induced spreading of measles virus hemagglutinin at the surface of chronically infected cells.
    Cell. 1975 Aug;5(4):351-9 PMID: 808272
  72. The formation and fate of virus antigen-antibody complexes.
    J Immunol. 1977 Jan;118(1):316-22 PMID: 830754
  73. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Proc Natl Acad Sci U S A. 1975 Apr;72(4):1622-6 PMID: 165518
  74. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis.
    Cell Immunol. 1976 Mar 1;22(1):98-109 PMID: 1277295
  75. Transmembrane communication in cells chronically infected with measles virus.
    J Cell Biol. 1979 May;81(2):396-402 PMID: 381319
  76. Complement.
    Annu Rev Biochem. 1975;44:697-724 PMID: 1094920
  77. Electron microscopic study of measles virus infection: unusual antibody-triggered redistribution of antigens on giant cells.
    J Virol. 1979 Feb;29(2):666-76 PMID: 107326
  78. Cell-mediated cytotoxicity against measles virus in SSPE. I. Enhancement by antibody.
    J Immunol. 1977 Jan;118(1):291-5 PMID: 830752
  79. Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus.
    Nature. 1974 Sep 27;251(5473):350-2 PMID: 4372535
  80. Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells.
    Transplant Rev. 1972;13:91-114 PMID: 4617353
  81. Redistribution and modulation of Gross murine leukemia virus antigens induced by specific antibodies.
    J Natl Cancer Inst. 1979 Jan;62(1):169-80 PMID: 281570
  82. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.
    J Exp Med. 1978 Dec 1;148(6):1620-7 PMID: 214512
  83. The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice.
    J Immunol. 1978 Oct;121(4):1437-45 PMID: 701803
  84. Cell cycle-dependent immune lysis of Moloney virus-transformed lymphocytes: presence of viral antigen, accessibility to antibody, and complement activation.
    Proc Natl Acad Sci U S A. 1971 Oct;68(10):2584-8 PMID: 4944633
  85. Functional interactions of viral and histocompatibility antigens at tumor cell surfaces.
    Proc Natl Acad Sci U S A. 1975 Dec;72(12):5066-70 PMID: 1108012
  86. Differences in antibodies to the surface components of mumps virus after immunization with formalin-inactivated and live vaccines.
    J Infect Dis. 1978 Nov;138(5):672-6 PMID: 712121
  87. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.
    N Engl J Med. 1968 Oct 24;279(17):893-900 PMID: 20617594
  88. Subacute sclerosing panencephalitis: a review.
    Curr Top Microbiol Immunol. 1972;57:1-38 PMID: 4625472
  89. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.
    J Exp Med. 1977 Jul 1;146(1):184-200 PMID: 301544
  90. Demonstration of T-cell and K-cell cytotoxicity against measles-infected cells in normal subjects, multiple sclerosis and subacute sclerosing panencephalitis.
    Clin Exp Immunol. 1977 Oct;30(1):22-31 PMID: 304777
  91. Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells.
    J Immunol. 1977 Mar;118(3):729-35 PMID: 191525
  92. Antigenic modulation in vitro. II. Modulation of thymus-leukemia (TL) antigenicity requires complement component C3.
    J Immunol. 1978 Jan;120(1):188-97 PMID: 627716
  93. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell.
    Nature. 1979 Jun 7;279(5713):529-30 PMID: 450095
  94. Expression of H-2 and Moloney leukemia virus-determined cell-surface antigens in synchronized cultures of a mouse cell line.
    Proc Natl Acad Sci U S A. 1971 Mar;68(3):566-9 PMID: 5276763
  95. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
    J Exp Med. 1978 May 1;147(5):1314-33 PMID: 650156
  96. Complement and cell membranes.
    Transplant Rev. 1976;32:72-92 PMID: 824770
  97. Identification of lipids synthesized and released by tumor cells under attack by antibody and complement.
    J Immunol. 1978 May;120(5):1644-50 PMID: 659869
  98. Thymus dependence of viral antigens.
    Nature. 1975 Aug 21;256(5519):654-6 PMID: 1080258
  99. Lysis of human cultured lymphoblastoid cells by cell-induced activation of the properdin pathway.
    Science. 1977 Mar 4;195(4281):878-80 PMID: 402691
  100. Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.
    J Cell Biol. 1975 Dec;67(3):835-51 PMID: 811671
  101. Inhibition of viral transcriptase by immunoglobulin directed against the nucleocapsid NS protein of vesicular stomatitis virus.
    J Virol. 1975 Jun;15(6):1357-66 PMID: 49440
  102. Acute viral infection: tissue injury mediated by anti-viral antibody through a complement effector system.
    J Immunol. 1971 Nov;107(5):1274-80 PMID: 5000724
  103. Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4622-6 PMID: 291990
  104. Rosette formation of human erythrocytes on cultured cells of tumour origin and activation of complement by cell membrane.
    Nature. 1974 Apr 5;248(448):521-2 PMID: 4522910
  105. Demonstration of cytotoxic antibodies in rabbits bearing tumors induced by Shope fibroma virus.
    Infect Immun. 1972 Mar;5(3):352-8 PMID: 4344218
  106. Studies on the persistent infection with measles virus in HeLa cells. 3. Immunolysis of cells in carrier state by anti-measles sera.
    Jpn J Microbiol. 1971 Jul;15(4):341-50 PMID: 5000619
  107. Inhibition or enhancement of immunological injury of virus-infected cells.
    Proc Natl Acad Sci U S A. 1971 Dec;68(12):3073-7 PMID: 5316196
  108. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Proc Natl Acad Sci U S A. 1978 Aug;75(8):3948-52 PMID: 279011
  109. Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin.
    Prog Med Virol. 1975;19:84-119 PMID: 164055
  110. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
    J Immunol. 1977 Jan;118(1):282-90 PMID: 830751
  111. Simultaneous occurrence of immunoglobulin-dependent and immunoglobulin-independent mechanisms in natural cytotoxicity of human lymphocytes.
    J Immunol. 1979 Jun;122(6):2251-60 PMID: 448127
  112. Induction and kinetics of natural killer cells in humans following interferon therapy.
    Nature. 1979 Nov 22;282(5737):417-9 PMID: 503223
  113. Antibody-induced modulation and shedding of mammary tumor virus antigens on the surfaces of GR ascites leukemia cells as compared with normal antigens.
    J Natl Cancer Inst. 1976 May;56(5):1019-29 PMID: 186612
  114. THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. II. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN ANTIGEN DOSE REQUIREMENT FOR SUSTAINED SYNTHESIS, ANAMNESIS, AND SENSITIVITY TO X-IRRADIATION.
    J Exp Med. 1964 Jan 1;119:21-39 PMID: 14113114
  115. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
    Eur J Immunol. 1978 Jul;8(7):453-8 PMID: 211040
  116. Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization.
    J Exp Med. 1974 Apr 1;139(4):902-24 PMID: 4593239
  117. Modulation of mouse mammary tumor virus production in the MJY-alpha cell line.
    J Virol. 1978 Nov;28(2):611-23 PMID: 214582
  118. Antibody-mediated cytotoxicity after measles virus infection.
    J Immunol. 1975 Jan;114(1 Pt 1):93-8 PMID: 803529
  119. Natural killer cells: characteristics and regulation of activity.
    Immunol Rev. 1979;44:43-70 PMID: 761939
  120. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    J Immunol. 1975 Mar;114(3):1077-82 PMID: 1089724
  121. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    J Exp Med. 1976 Oct 1;144(4):1076-93 PMID: 978134
  122. Moloney virus-induced cell surface antigens and histocompatibility antigens are located on distinct molecules.
    J Immunol. 1979 May;122(5):1697-704 PMID: 87439
  123. Immunological destruction of herpes simplex virus I infected cells.
    Nature. 1974 Oct 11;251(5475):542-3 PMID: 4371311
  124. Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis.
    Infect Immun. 1978 Aug;21(2):442-7 PMID: 80379
  125. CYTOTOXIC ASSAYS AND OTHER IMMUNOLOGIC STUDIES OF LEUKEMIAS INDUCED BY FRIEND VIRUS.
    J Natl Cancer Inst. 1963 Aug;31:411-23 PMID: 14046631
  126. Complement activation by measles virus cytotoxic antibodies: alternative pathway C activation by hemagglutination-inhibition antibodies but classical activation by hemolysin antibodies.
    J Immunol. 1977 Feb;118(2):533-9 PMID: 402419
  127. Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins.
    J Immunol. 1978 Jun;120(6):1849-55 PMID: 659880
  128. Species source of complement in viral-immune and other cytolytic reactions.
    Proc Soc Exp Biol Med. 1970 Feb;133(2):615-9 PMID: 4313147
  129. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    J Exp Med. 1977 Jul 1;146(1):22-33 PMID: 559720
  130. Immunologic injury in measles virus infection. IV. Antigens modulation and abrogation oflymphocyte lysis of virus-infected cells.
    Clin Immunol Immunopathol. 1978 Jan;9(1):55-62 PMID: 618410
  131. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Clin Exp Immunol. 1976 Jul;25(1):1-5 PMID: 186222
  132. Hormonal regulation of peptide receptors and target cell responses.
    Nature. 1979 Jul 12;280(5718):109-16 PMID: 233264
  133. Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody.
    Proc Natl Acad Sci U S A. 1967 Sep;58(3):954-7 PMID: 5233851
  134. Separate pathways of C activation by measles virus cytotoxic antibodies: subclass analysis and capacity of F(ab) molecules to activate C via the alternative pathway.
    J Immunol. 1978 Sep;121(3):1206-12 PMID: 690438
  135. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.
    Immunol Rev. 1979;44:125-163 PMID: 153888
  136. Influenza virus effects on cell membrane proteins.
    Science. 1970 Jan 9;167(3915):202-5 PMID: 5409648
  137. Antibody-dependent cell-mediated cytolysis (ADCC): analyses and projections.
    Prog Allergy. 1977;22:1-44 PMID: 325576
  138. Inhibition of influenza-immune T cell effector function by virus-specific hybridoma antibody.
    J Immunol. 1979 Sep;123(3):1343-6 PMID: 313952
  139. Antibody-induced linkages of plasma membrane proteins to intracellular actomyosin-containing filaments in cultured fibroblasts.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5584-8 PMID: 146200
  140. Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantisera.
    Proc Natl Acad Sci U S A. 1973 Dec;70(12):3665-8 PMID: 4128546
  141. Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression.
    J Exp Med. 1977 Jun 1;145(6):1449-68 PMID: 301173
  142. Suppression of established Friend virus leukemia by statolon. IV. Role of humoral antibody in the development of a dormant infection.
    J Natl Cancer Inst. 1972 Mar;48(3):665-73 PMID: 5062046
  143. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.
    J Exp Med. 1979 Jul 1;150(1):10-9 PMID: 286744
  144. Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus.
    Med Microbiol Immunol. 1978 Nov 17;166(1-4):71-9 PMID: 723792
  145. Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography.
    J Exp Med. 1972 Oct 1;136(4):885-906 PMID: 4626851
  146. Inhibition of virus release by antibodies to surface antigens of influenza viruses.
    J Virol. 1974 Feb;13(2):269-75 PMID: 4855737
  147. Mouse natural killer cells: induction specificity, and function.
    J Immunol. 1978 Nov;121(5):1631-5 PMID: 361888
  148. Mechanism of selective nonspecific cell-mediated cytotoxicity of virus-infected cells.
    Nature. 1976 Mar 25;260(5549):369-70 PMID: 176600
  149. Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement.
    J Immunol. 1979 May;122(5):1994-9 PMID: 376729
  150. Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragments.
    J Immunol. 1979 Nov;123(5):2144-9 PMID: 489977
  151. The membrane structure of lipid-containing viruses.
    Biochim Biophys Acta. 1974 Apr 8;344(1):51-94 PMID: 4598854
  152. Immunoglobulin binding to herpes virus-induced Fc receptors inhibits virus growth.
    Nature. 1977 Sep 15;269(5625):251-2 PMID: 201851
  153. Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation.
    J Immunol. 1978 Jul;121(1):371-6 PMID: 670706
  154. Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. III. Periodic production of a cell surface glycoprotein and changes in reactivity with cytotoxic T cells and anti-H-2d sera.
    J Immunol. 1979 Jun;122(6):2245-50 PMID: 312862
  155. Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.
    J Exp Med. 1979 Apr 1;149(4):870-82 PMID: 372483
  156. ADSORPTION OF SENSITIZED SHEEP ERYTHROCYTES TO HELA CELLS INFECTED WITH HERPES SIMPLEX VIRUS.
    Nature. 1964 Jun 27;202:1364-5 PMID: 14210996
  157. Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties.
    J Immunol. 1978 Aug;121(2):726-30 PMID: 681755
  158. Failure of terminal complement components to induce lysis of Moloney virus transformed lymphocytes.
    J Immunol. 1974 Feb;112(2):866-8 PMID: 4855965
  159. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20 PMID: 276881
  160. Complement enhances antiviral antibody-dependent cell cytotoxicity.
    Nature. 1977 Mar 31;266(5601):456-8 PMID: 859615
  161. Interactions between human lymphocytes and paramyxovirus-infected cells: adsorption and cytotoxicity.
    J Immunol. 1977 Apr;118(4):1132-7 PMID: 300397
  162. Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement.
    J Immunol. 1977 Jan;118(1):348-54 PMID: 830758
  163. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.
    J Exp Med. 1978 Mar 1;147(3):844-53 PMID: 632750
Article Info
Journal
Advances in immunology
Abbr.
Adv Immunol
ISSN
0065-2776
DOI
10.1016/s0065-2776(08)60045-0
Published
1980-00-00
Pages
209-60
Language
English
Region
United States
NLM ID
0370425
PMCID
PMC7173112
Subset
IM
Grants
NIAID NIH HHS · AI-07007 · United States
NIAID NIH HHS · AI-09484 · United States
NINDS NIH HHS · NS-12428 · United States
External Links
PubMed source DOI: 10.1016/s0065-2776(08)60045-0 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2